5AM Partners VII reports Skye Bioscience share sale worth $64,858.44

5AM Partners VII, a 10% owner, sold 33,892 Skye Bioscience common shares on Sep. 16, 2026 at $1.91. Holdings fell to 142,463 shares held via 5AM Ventures II, LP; 5,616 via 5AM Co-Investors II, LP. 5AM Ventures VII, LP reported 981,269 shares beneficially owned following the filing. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Skye Bioscience Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001231919-26-001197), on September 18, 2026, and is solely responsible for the information contained therein. (C)